If We Told You Flossing Could Balance Blood Sugar & Decrease Inflammation, Would You Finally Do It?

Ah, the dreaded dentist visit. We all know we have to go every six months, and at the end we all get the same friendly advice, “Make sure to floss!” And while I’ve always been a pretty consistent flosser, I didn’t know how important it was until I started researching the second most diverse microbiome in the body: the oral microbiome. And as a medical doctor who helps my patients tend to their gut microbiomes almost daily, I was fascinated by the huge role the oral microbiome (and flossing!) plays in our overall health.

When you really think about it, it makes sense that our oral cavity houses a very special ecosystem. Our mouths are, after all, where digestion actually begins—not to mention, they are the primary entrance to the rest of our body, where we do a lot of interacting with the outside world. Scientists have been turning their attention to this special community of mouth organisms for decades. In fact, a book published in 1890, The Micro-organisms of the Human Mouth, promoted our current habits of brushing and flossing.

So what’s so special about our oral microbiota? The bugs in our mouth form biofilms, which is a fancy word used to describe complex groups of microorganisms. You may have heard of plaque, which is essentially a multi-organism biofilm layer on the surface of the teeth. If these growing plaques are not detached, it can lead to dysbiosis, allowing disease-promoting bugs to take hold and cause issues like cavities, gingivitis, and periodontitis (the most severe form of gum disease that eats away at both the gums and teeth). Even more importantly, oral dysbiosis has a reach far beyond the mouth. These oral microbes do make their way to the rest of the digestive tract—and actually, there is a 45 percent overlap in species seen in the oral and fecal microbiota.

Aside from the gut, these oral bad bugs can gain access to the rest of the body by going through our mouth membranes and periodontal pockets (separations between the gums and the teeth) and entering the bloodstream. When this occurs, the immune response can be altered, inflammatory pathways can be activated, and disease can occur at a site far, far away from the mouth. Periodontal disease has actually been linked to both diabetes and cardiovascular disease. How in the world does that happen? The bacteria of periodontal disease produce lipopolysaccharide (LPS), which changes the body’s control of sugar levels and contributes to atherothrombogenesis (a big term to describe an accumulation of plaque and clotting factors in the heart arteries). Periodontal bacteria’s DNA has even been found in the coronary artery plaques of those who suffered a heart attack.

Click here to read more.

 

Please follow and like us:

NIH Launches Human Microbiome Project

NIH Roadmap Effort to Use Genomic Technologies To Explore Role of Microbes in Human Health and Disease.

The human body contains trillions of microorganisms, living together with human cells, usually in harmony. Because of their small size, however, microorganisms make up only about one to two percent of the body’s mass. Many microbes maintain our health, while others cause illness. Yet, surprisingly little is known about the role this astounding assortment of bacteria, fungi and other microbes play in human health and disease. To better understand these interactions, the National Institutes of Health (NIH) today announced the official launch of the Human Microbiome Project. The human microbiome is the collective genomes of all microorganisms present in or on the human body.

“The human microbiome is largely unexplored,” said NIH Director Elias A. Zerhouni, M.D. “It is essential that we understand how microorganisms interact with the human body to affect health and disease. This project has the potential to transform the ways we understand human health and prevent, diagnose and treat a wide range of conditions.”

Part of the NIH’s Roadmap for Medical Research, the Human Microbiome Project will award a total of $115 million to researchers over the next five years. Initially, researchers will sequence 600 microbial genomes, completing a collection that will total some 1,000 microbial genomes and providing a resource for investigators interested in exploring the human microbiome. Other microbial genomes are being contributed to the collection by individual NIH institutes and internationally funded projects. A meeting between international partners was recently convened to discuss forming an international consortium.

Researchers will then use new, comprehensive laboratory technologies to characterize the microbial communities present in samples taken from healthy human volunteers, even for microbes that cannot be grown in the laboratory. The samples will be collected from five body regions known to be inhabited by microbial communities: the digestive tract, the mouth, the skin, the nose, and the female urogenital tract. Demonstration projects will subsequently be funded to sample the microbiomes from volunteers with specific diseases. This will allow researchers to correlate the relationship between changes in a microbiome present at a particular body site to a specific illness.

“We now understand that there are more microbial cells than human cells in the human body. The Human Microbiome Project offers an opportunity to transform our understanding of the relationships between microbes and humans in health and disease,” said Dr. Alan Krensky, the director of the Office of Portfolio Analysis and Strategic Initiatives (OPASI), which oversees the NIH Roadmap for Medical Research.

While the term “microbiome” may be relatively new in biomedical research, most people are familiar with some of the effects — both good and bad — that microbes can have on our health. Consider the example of the biggest reservoir of microbes in humans: the digestive tract. The human gut harbors many beneficial microorganisms, including certain bacteria called probiotics. There is evidence these probiotics, found in dietary supplements, yogurt and other dairy products as well as various soy products, can stimulate the immune system and improve digestive functions. In contrast, previous research suggests that variations in the composition of microbial communities may contribute to chronic health conditions, including diabetes, asthma, obesity and digestive disorders. […]

Click here to view original web page at www.nih.gov

Please follow and like us: